Wellington Shields & Co’s Insmed INSM Stock Holding History

Wellington Shields & Co’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,950	Closed	-$569K	–	329
2025 Q3	$569K	Buy	+3,950	New	+$484K	0.15%	134

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Shields & Co's INSM Position: Q4 2025 in Review

Wellington Shields & Co sold out of Insmed (INSM) in Q4 2025, closing a stake of 3,950 shares — an estimated $569K sold.

Wellington Shields & Co first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $569K in Q3 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

Wellington Shields & Co reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
Wellington Shields & Co sold 3,950 Insmed shares in Q4 2025, an estimated $569K.
Wellington Shields & Co first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
Wellington Shields & Co's Insmed position peaked at $569K in Q3 2025.
677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Wellington Shields & Co's 13F filing for Q4 2025, filed 9 Feb 2026.